$10 million for ADHD medicine on the PBS

Australian Government

22 February 2019 - The Australian Government will invest $10 million to expand access to a medicine for attention deficit hyperactivity disorder.

The Liberal National Government will invest $10 million to expand access to a medicine for attention deficit hyperactivity disorder (ADHD).

Intuniv (guanfacine) for the treatment of ADHD will be made available as an add-on therapy to other ADHD medicines on the Pharmaceutical Benefits Scheme from March 1 this year.

Read Minister of Health press release

Michael Wonder

Posted by:

Michael Wonder